Markets:

Overview

News

Currencies

International

Treasuries

Amgen (NQ:AMGN)

403.72 -4.11 (-1.01%)

Streaming Delayed Price Updated: 11:16 AM EDT, Aug 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

69 70 Next >

Amgen's Diversified Portfolio To Drive Long-Term Growth, Though Uncertainties Loom, Analyst Says ↗

March 28, 2024

Raymond James resumes coverage of Amgen highlighting its diversified portfolio and strong presence across therapeutic areas for sustainable long-term growth. Innovative pipeline in oncology, rare...

Via Benzinga

Amgen Options Trading: A Deep Dive into Market Sentiment ↗

March 28, 2024

Via Benzinga

7 Stocks That Will Drive the Weight Loss Drugs Market

March 28, 2024

The booming weight loss drug market presents both lucrative potential and significant risks for investors seeking to capitalize on the global obesity crisis.

Via MarketBeat

3 Biotech Stocks to Buy on the Dip: March 2024 ↗

March 27, 2024

Some of the best opportunities can be found in dips in some of the top biotech stocks to buy. In fact, here are three.

Via InvestorPlace

7 Dow Stocks to Buy on the Dip: March 2024 ↗

March 27, 2024

Analysts expect that the market may be heading toward a correction. These are seven of the best Dow stocks to buy when prices pull back.

Via InvestorPlace

Topics Stocks

Is Amgen Stock a Buy Now? ↗

March 21, 2024

There are some worrying signs.

Via The Motley Fool

Looking At Amgen's Recent Unusual Options Activity ↗

March 14, 2024

Via Benzinga

Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich ↗

March 25, 2024

Some of the market’s favorite biotech stocks have created immense wealth, as evidenced with the recent weight-loss drug stock boom.

Via InvestorPlace

Buffett’s Backdoor Buys: 3 Stocks His Secret Portfolio Is Quietly Accumulating ↗

March 25, 2024

Warren Buffett stocks and Berkshire Hathaway's portfolio of companies are hidden investment vehicles hiding in plain sight.

Via InvestorPlace

Hot Stocks: The 3 Best Opportunities for Investing in Biotech ↗

March 21, 2024

Biotech stocks can offer some of the best risk vs. reward payoff in the stock market. These three are ones to buy now.

Via InvestorPlace

Hot Stocks: The 3 Best Opportunities for Investing in the Dow ↗

March 20, 2024

Although these Dow stocks are mature enterprises, they still have enough in the tank to pull off some surprises.

Via InvestorPlace

Topics Stocks

10 Health Care Stocks Whale Activity In Today's Session ↗

March 18, 2024

Via Benzinga

(AMGN) - Analyzing Amgen's Short Interest ↗

March 06, 2024

Via Benzinga

4 Oversold Large Cap Stocks Yielding High Dividends

March 14, 2024

Overlooked, oversold large-cap stocks offer compelling dividend yields for investors seeking income and potential capital appreciation

Via MarketBeat

Topics Artificial Intelligence Economy

Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields ↗

March 13, 2024

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

Via Benzinga

The Dow’s Best Friends: 3 ‘Dogs’ Ready to Fetch Huge Returns ↗

March 11, 2024

The Dogs of the Dow strategy is one of the best yearly strategies investors should use to make some good money.

Via InvestorPlace

Topics Stocks

Obesity Drugs 2024: The Skinny on the Top 3 Weight-Loss Stocks ↗

March 10, 2024

With therapeutics focused on slimming down skyrocketing, it’s time to consider these top weight-loss stocks.

Via InvestorPlace

The AI Race Gets Litigious ↗

March 09, 2024

We've also got a look at the role of patents in pharmaceuticals and the "patent cliff" looming over the next decade.

Via The Motley Fool

Topics Artificial Intelligence Intellectual Property

9 Health Care Stocks Whale Activity In Today's Session ↗

March 08, 2024

Via Benzinga

Medicare's Ambitious Drug Price Negotiation Plan: President Joe Biden Calls To Expand Targeted Medicines To 50 Annually by 2029 ↗

March 07, 2024

Explore President Biden's plan to expand Medicare drug negotiations, targeting at least 50 drugs annually. Uncover the impact on pharmaceutical profits and the broader health-care policy proposals,...

Via Benzinga

Is It Time to Buy February's 3 Worst-Performing Dow Jones Stocks? ↗

March 06, 2024

It's only a bargain price if it's actually worth owning.

Via The Motley Fool

Topics Stocks

It’s Time! 3 Dodgy Pharma Stocks to Sell in February ↗

March 04, 2024

Explore pharma stocks to sell in February: Eli Lilly, Amgen, BioNTech face overvaluation, volatility, urging investor action.

Via InvestorPlace

After Soaring 222% in 1 Day, Is Janux Therapeutics Stock a Buy? ↗

March 02, 2024

The biotech tantalized investors with a very promising data update.

Via The Motley Fool

Eli Lilly Stock And The Road To 1,000: Weight-Loss Drugs Could Generate $81 Billion ↗

March 01, 2024

Wall Street isn't properly taking into account Lilly's next-generation drugs, an analyst says.

Via Investor's Business Daily

Apple Sinks After Wall Street Titan Pulls Magnificent 7 Stock From Conviction List ↗

March 01, 2024

Goldman Sachs is removing Apple from its Conviction List of buy-rated stocks. Looking at the potential reasons why and who replaced the tech giant.

Via Benzinga

Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields ↗

March 01, 2024

Via Benzinga

2 Stocks That Could Turn $1,000 Into $2,500 in 5 Years ↗

March 01, 2024

It will take a lot, but this goal isn't out of reach for these stocks.

Via The Motley Fool

Better Dividend Growth Stock: AbbVie or Amgen? ↗

February 29, 2024

A strong case can be made for owning both of these dividend growth stocks. But one of them is the better buy.

Via The Motley Fool

Amazon Stock: Why it's Finally Included in the Dow Index

February 29, 2024

Amazon replaced Walgreens in the Dow. While a positive move for Amazon, any impact on the stock's price may be limited due to low index weighting.

Via MarketBeat

Topics Economy Stocks

Amgen's Upcoming Catalysts In 2024 Set To Unlock Multi-Billion Dollar Markets, Says Goldman Sachs ↗

February 26, 2024

Amgen's growth outlook in 2024, with updates on key programs and upcoming catalysts. Goldman Sachs sees significant opportunities despite exclusivity losses. Dive into potential market moves and...

Via Benzinga

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

69 70 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.